healthcaretrends

The global multiplex assays market is projected to reach USD 3.35 Billion in 2023 from USD 2.17 Billion in 2017, at CAGR of 7.5%. In the current market scenario, there is a growing demand for multiplex assays. The major factors driving the growth of the market include the adoption of Companion Diagnostics for increasing the safety & efficacy of therapies and the advantages of multiplex assays over conventional singleplex assays.

Download PDF Brochure @
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=61593314

Opportunity: Monitoring of biosimilars in autoimmune diseases

Anti-TNF-alpha biologics are proving to be an effective treatment for autoimmune diseases, such as rheumatoid arthritis (RA) and inflammatory bowel disease (IBD). With the increasing healthcare costs as well as patent expirations, the number of R&D activities focusing on the development of biosimilars have increased over the last few years. The launch of biosimilars in the market is increasing the need for the better understanding of potential differences in biosimilar immunogenicity as well as their safety and efficacy profiles as compared to their precursors. For instance, TNF-alpha blockers, such as infliximab and adalimumab, both can trigger immunogenicity responses and researchers have hypothesized that their biosimilars drugs (CT-P13) may also promote immunogenicity. Therefore, it is vital to develop methods for the TDM of biosimilar drugs for autoimmune diseases to ensure effective patient care.

Driver: Use of TDM in traditional anticancer therapies

TDM provides valuable guidance for the dose adjustment of antibiotics, immunosuppressants, antiepileptics, and other drugs. However, its use in traditional anticancer therapies has been limited. The requirement of multiple blood samples to adequately define the systemic exposure of anticancer drugs is the major issue encountered while testing for anticancer therapies.

Drugs in blood samples have a short elimination half-life and are given by intermittent intravenous injections; this makes the entire monitoring process difficult to analyze. However, newer targeted anticancer therapies have different pharmacokinetic (PK) and dosing characteristics as compared with traditional cytotoxic drugs. Owing to this, it is now possible to estimate the steady-state drug exposure with a single trough-level measurement. Recent evidence indicates that certain PK parameters, including trough levels, are correlated with clinical outcomes for many cytotoxic agents, including imatinib, sunitinib, rituximab, and cetuximab.

Although current evidence is not sufficient to make TDM a compulsory practice, investigations with encouraging results will have a practical place in the clinical care of patients with cancer. With the increasing incidence of cancer and focus on reducing the adverse effects of drugs, the monitoring of antineoplastic drugs is expected to gain more importance in the treatment of cancer.

North America is expected to account for the largest market share

North America is expected to account for the largest share of this market, followed by Europe. Growth in the North American market is mainly driven by the increasing per capita healthcare expenditure and the presence of technologically advanced healthcare infrastructure in the region. Initiatives taken by different government associations are also anticipated to boost market growth in the coming years.

Request Sample Pages @
https://www.marketsandmarkets.com/requestsampleNew.asp?id=61593314

Key Players:

Abbott Laboratories, Hoffmann-La Roche, Siemens Healthineers, Thermo Fisher Scientific, Danaher Corporation, Bio-Rad Laboratories, Biomérieux, Bühlmann Laboratories, Sekisui Medical, Randox Laboratories.

The global neuromodulation market is projected to reach USD 8.8 billion by 2025 from USD 5.8 billion in 2020, at a CAGR of 8.6%. The growth of this market is driven majorly by the rising prevalence of neurological disorders, increasing research into expanding the applications of neuromodulation, and awareness on neurodegenerative disorders. However, the high cost of neuromodulation procedures and equipment, along with the dearth of a trained workforce, is expected to restrain the growth of this market during the forecast period.

Parkinson’s disease held the largest share of the deep brain stimulation market, by application

Based on application, the deep brain stimulation market is segmented into Parkinson’s disease, tremor, depression, and other DBS applications. Parkinson’s disease accounted for the largest share of this market in 2019. The growth of this segment is attributed to the rising incidence of the disease and growing R&D activity in this area.

Download PDF Brochure @
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=921

The Asia Pacific neuromodulation market is expected to grow at the highest CAGR during the forecast period

The Asia Pacific is expected to grow at the highest rate in the market. The major factors driving the growth of this market include the high incidence of neurological disorders, increasing public and private investments, and ongoing research.

Leading Market Players in Neuromodulation Market:

The prominent players in the neuromodulation market include Medtronic (Ireland), Boston Scientific Corporation (US), Abbott (US), LivaNova (UK), Synapse Biomedical, Inc. (US), Nevro Corporation (US), NeuroSigma (US), NeuroPace (US), Neuronetics (US), and BioControl Medical (Israel). Major players have focused on product launches, agreements, and partnerships to increase their shares in the global market.

Medtronic is one of the leading players in the neuromodulation market. The company’s leading position can be attributed to its wide portfolio of neuromodulation devices and strong geographical footprint. The company operates in the US, Europe, and the Asia Pacific. It serves clinicians, physicians, hospitals, and patients in more than 160 countries. R&D is a key area of focus for Medtronic—it invested USD 2,330 million in 2019, as compared to USD 2,256 million in 2018 and USD 2,193 million in 2017. The company also focuses on organic as well as inorganic growth strategies to gain a competitive edge.

Request Sample Pages @
https://www.marketsandmarkets.com/requestsampleNew.asp?id=921

Recent Development in Global Neuromodulation Market:

1. In 2019, NeuroSigma signed a partnership agreement with Teijin Limited (Teijin) (Japan). The partnership granted Teijin Pharma, the core company of Teijin’s healthcare business, exclusive rights to market NeuroSigma’s Monarch eTNS system in Japan, as well as the company’s TNS patent rights in Japan related to the non-invasive treatment of ADHD.

2. In 2018, Abbott signed an agreement with the National Institutes of Health (NIH) (US). As per the agreement, Abbott will provide neuromodulation technologies, including directional DBS, SCS, and DRG therapy, for NIH research to explore their applications in chronic pain and progressive movement disorders.

3. In 2017, Medtronic signed a partnership agreement with Mercy (US) to establish a new data sharing and analysis network that helps gather clinical evidence for medical device innovation and patient access

Radiotherapy Market growth is largely driven by factors such as technological advancements, the rising prevalence of cancer, the increasing number of conferences and symposia focusing on spreading awareness about the benefits of radiotherapy, and the growing use of particle therapy for cancer treatment. The emerging markets, growing government and private investments to meet the increasing demand for cancer treatment, and the improving reimbursement scenario are expected to present a wide range of growth opportunities for market players.

The radiotherapy market is projected to grow from an estimated $5.6 billion in 2018 to $6.8 billion by 2023, at a CAGR of 4.1%.

Download PDF Brochure @
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=567

Driver: Technological advancement

Over the last decade, the radiotherapy devices market has seen significant technological advancements. These advancements have helped in the development of more effective, low-cost, and easy-to-use radiotherapy products with improved and precise radiation dose delivery to offer increased efficiency in targeting tumors. The advancement from 2D to 3D conformal radiotherapy with real-time imaging has enabled high conformity of radiation to the target (with minimal exposure to normal tissue) and dose escalation with improved tumor control. Products that provide these benefits are expected to have a very high growth potential in a short time span, especially in mature markets where the adoption rate of technologically advanced products is high.

Such technological advancements focus on improving the functionality of radiotherapy delivery systems and expanding their application areas. Considering these benefits, the adoption of radiotherapy is increasing in various hospitals and independent radiotherapy centers.

Asia Pacific is expected to grow at the fastest rate in the radiotherapy market

The Asia Pacific is one of the major revenue-generating regions in the radiotherapy market. China, India, and Japan are the major countries responsible for the high growth of this regional market owing to factors such as the increasing per capita income, improving healthcare infrastructure, and supportive government activities in these emerging countries. Furthermore, the increasing geriatric population, the growing incidence of cancer, and the rising acceptance of radiotherapy procedures and devices are also driving the growth of this regional market.

Request Sample Pages @
https://www.marketsandmarkets.com/requestsampleNew.asp?id=567

Key Players:

Varian Medical Systems, Inc. (US), Elekta AB (Sweden), and Accuray Incorporated (US) dominated the radiotherapy market. Other players in this market include Ion Beam Applications SA (Belgium), ViewRay, Inc. (US), IsoRay Medical, Inc. (US), Hitachi Ltd. (Japan), Panacea Medical Technologies Pvt. Ltd. (India), Provision Healthcare (US), and Mevion Medical Systems, Inc. (US)

Varian Medical Systems (US) is one of the leading players in the global radiotherapy market. Its broad portfolio of radiotherapy systems and brachytherapy products is the key factor accounting for its large share in this market. The company has adopted both organic and inorganic growth strategies such as agreements, partnerships, collaborations, product launches, and contracts to maintain its top position in the field of radiotherapy. The company is also focused on providing training and conducting workshops to increase the adoption of its products.

The enteral feeding devices market has evolved significantly owing to various technological advancements, such as programming and safety features in feeding pumps as well as user-friendly and portable feeding pumps. Factors such as rising healthcare costs; surge in the number of preterm births; growth in the aging population; rising prevalence of chronic diseases such as diabetes, cancer, gastrointestinal diseases, and neurological disorders; growing awareness of enteral nutrition; and rapid improvements in healthcare facilities in emerging countries are expected to further drive the market during the forecast period.

MarketsandMarkets forecasts the enteral feeding devices market to grow from USD 2.99 billion in 2019 to USD 4.14 billion by 2024, at a Compound Annual Growth Rate (CAGR) of 6.7%.

Download PDF Brochure @
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=183623035

Driver: Shift from Parenteral to Enteral Nutrition

Enteral nutrition is more physiological, with fewer complications as compared to parenteral nutrition. The major advantage of enteral nutrition is the maintenance of the GI mucosal barrier, stimulating intestinal blood flow. Enteral administration also helps in maintaining small intestine mass and pancreatic functions, improves healing & recovery, reduces muscle catabolism, and lowers the risk of infection and contamination. According to an article published in the German Medical Science journal, major septic complications affect only 3% of patients on enteral nutrition as compared to over 20% of those on parenteral nutrition.

Technological advancements have also led to the development of compact and portable enteral feeding pumps, which are constructed using materials that prevent cracking in high-stress applications. Advanced features in pumps include appropriate programming options, programmed flushing intervals, multiple language options, occlusion pressure alarm options, history of previous feed rates, and screen and program lock-out features to prevent manipulation.

The oncology segment to accounted for the largest share in Enteral Feeding Devices Market:

The oncology segment accounted for the largest share of the global market. The increase in the prevalence of various types of cancers, especially head and neck cancers, cancers of the gastrointestinal system, lung cancer, and liver cancer, is expected to play a major role in the higher adoption of enteral feeding devices used to provide clinical nutrition to cancer patients.

Request Sample Pages @
https://www.marketsandmarkets.com/requestsampleNew.asp?id=183623035

High growth opportunities in emerging countries for Enteral Feeding Devices Market:

The Asia Pacific region is expected to offer potential growth opportunities to market players in the coming years. This can primarily be attributed to the diversified healthcare markets in this region, growing incidence of infectious and chronic disorders, and increasing R&D initiatives to develop innovative medical technologies. In addition, infrastructural developments in healthcare facilities, increasing healthcare expenditure, and the low-cost manufacturing advantage offered by emerging APAC countries are expected to encourage market players to invest in this region in the coming years.

Key Players:

Prominent players in the enteral feeding devices market include Fresenius Kabi AG (Germany), Avanos Medical, Inc. (US), Cardinal Health, Inc. (US), B. Braun Melsungen AG (Germany), Abbott Laboratories (US), Becton, Dickinson and Company (US), Boston Scientific Corporation (US), Cook Medical, Inc. (US), and CONMED Corporation (CONMED) (US).

The global biosimulation market is projected to reach USD 2,881 billion by 2022 from USD 1,375 billion in 2017, at a CAGR of 15.9%. Factors such as increase in R&D investments in the pharmaceutical and biotechnology industries, growing adoption of biosimulation software by regulatory bodies, technologically advanced QSP systems, need to curtail drug discovery and development costs, and growth in the biologics and biosimilars markets are driving the growth of the market.

Pharmaceutical and Biotechnology Companies Segment to Record the Highest CAGR:

Pharmaceutical and biotechnology companies are expected to form the largest share in 2017, and is projected to register the highest CAGR during the forecast period. Increased R&D budgets of pharmaceutical and biotechnology companies and increasing adoption of inorganic growth strategies by different biosimulation service providers are likely to boost the adoption of biosimulation solutions in the pharmaceuticals and biotechnology industry.

Download PDF Brochure @
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=838

Driver: Growth in the biologics and biosimilar market

Growth in the global biosimilars market is mainly driven by factors such as the growing pressure to curtail healthcare expenditures, growing demand for biosimilars due to their cost-effectiveness, rising incidence of various diseases, increasing number of off-patented drugs, positive outcomes in ongoing clinical trials, and rising demand for biosimilars in different therapeutic applications such as rheumatoid arthritis and blood disorders. As there is very little success in the R&D of new chemical entities, pharmaceutical companies are trying to find new applications for their existing drugs. As toxicity and other vital parameters of drug safety are already tested, biosimulation technologies are used to confirm the hypothesis of using the drugs for a new indication or disease.

Opportunity: Emerging applications

The emerging applications of biosimulation in defense, industrial bioprocessing, nutraceuticals, and agri-food production present significant opportunities for the growth of the global biosimulation market. Various biosimulation companies are adopting inorganic and organic growth strategies to expand the applications of their biosimulation software and services. In May 2017, the Institute of Life Science at Swansea University delivered an in silico drug discovery software platform for the UK Ministry of Defense for the development of antimicrobials to meet the needs of defense and security in the country. Likewise, in April 2017, Certara formed a partnership with the Australian Department of Defense. Certara’s d3 medicine company was selected to conduct a national audit to check the research and development capabilities and capacity of Australia’s medical countermeasures (MCM) product.

Request Sample Pages @
https://www.marketsandmarkets.com/requestsampleNew.asp?id=838 

Market Players:

Certara (US), Simulations Plus (US), Dassault Systèmes (France), Schrödinger (US), ACD/Labs (Canada), Chemical Computing Group (Canada), Physiomics (UK), Evidera (US), In silico biosciences (US), INOSIM Software (Germany), Insilico Biotechnology (Germany), LeadInvent Technologies (India), Rosa (US), Nuventra Pharma (US), and Genedata (Switzerland).

The biosurgery market to grow from USD 11,365.0 million in 2018 to USD 15,581.7 million by 2023, at a Compound Annual Growth Rate (CAGR) of 6.5% during the forecast period. The major factors that are expected to be driving the biosurgery market are the rising geriatric population, increase in the volume of surgeries and sports-related and trauma injuries, increasing clearance of biosurgery products by regulatory authorities and growing need for effective blood loss management in patients.

Download PDF Brochure @
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=166922302

Driver: Increasing volume of surgeries and prevalence of severe trauma injuries

Changing lifestyles and eating habits have resulted in a significant increase in the prevalence of obesity and other lifestyle disorders. This is a major factor responsible for the growth in the number of surgeries performed every year across the globe. Biosurgery products play a critical role in controlling blood loss, healing wounds, and in closing the surgical sites during different types of surgeries. Owing to the proven benefits of biosurgery products and the growing awareness for the same, the overall uptake of different surgical sealants and hemostatic agents during surgical procedures is increasing. This is one of the key contributors to the growth of the biosurgery market.

Opportunity: Untapped emerging markets

The penetration of biosurgery products is very low in the Asia Pacific, Latin America, and the Middle East and Africa. In the coming years, countries such as China, India, and Brazil are expected to offer significant growth opportunities for players operating in the biosurgery market. This is because the markets in these countries are characterized by a large patient base for target indications (such as cardiovascular, orthopedic, general/abdominal, and gynecological disorders), rising health awareness, growing healthcare expenditure, rising medical tourism, and rapidly developing healthcare infrastructure.

Request Sample Pages @
https://www.marketsandmarkets.com/requestsampleNew.asp?id=166922302

Key Players:

Baxter International (US), Johnson & Johnson (J&J) (US), Medtronic plc (Ireland), Sanofi (France), C.R. Bard (US), Integra LifeSciences (US), and Maquet holdings (Sweden), lead the global biosurgery market. Some of the other leading players in this market include Cohera Medical (US), Hemostasis LLC. (US), Stryker Corporation (US), B.Braun Melsungen AG (Germany), CSL Limited (Australia), Pfizer Inc. (US), and Cryolife Inc. (US).

The report "Temperature Management Market by Product (Surface & Intravascular System - Warming & Cooling), Application (Perioperative (Preoperative Care, Operating Room), Acute Care, Newborn Care), Medical Specialties (Pediatric, Orthopedic) - Global Forecast to 2024", is expected to grow from USD 2.6 billion in 2019 to USD 3.0 billion by 2024, at a CAGR of 3.2% during the forecast period. The increase in the incidence of chronic conditions and the subsequent increase in the number of surgical procedures are the key factors driving market growth.

Patient warming systems to account for the largest share of the global temperature management market in 2019
Based on product, the patient warming systems segment is expected to account for the largest share of the temperature management market in 2019. Factors such as the rising demand for these systems in diverse hospital settings and the increasing adoption rate of invasive warming in surgical procedures such as orthopedic surgeries, gynecology and obstetrics procedures, gastrointestinal procedures, and general surgeries driving the growth of this segment.

Download PDF Brochure@
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=141546773

General surgery to account for the largest share of the market, by medical specialty, in 2019
Based on medical specialty, the temperature management market is segmented into general surgery, cardiology, neurology, thoracic surgery, orthopedics, pediatrics, and other medical specialties. The general surgery segment is expected to dominate the market in 2019. The rising incidence of cancers such as breast cancer, colorectal cancer, liver cancer, GI disorders, and endocrine disorders, globally, and the increasing number of general surgical procedures are the major factors driving the growth of this segment.

North America to dominate the market in 2019
North America is estimated to grow at the highest CAGR during the forecast period. Factors such as the large volume of surgical procedures performed in the North American region, growth in the geriatric population, the rising incidence of cardiac arrests and neurological disorders, and the availability of technologically advanced products are the key factors supporting the growth of the temperature management market in North America.

Request Sample Pages@
https://www.marketsandmarkets.com/requestsampleNew.asp?id=141546773

Key Players:
The major companies in the global temperature management market include 3M Company (US), Medtronic (Ireland), Smiths Medical (US), Stryker (US), and ZOLL Medical (Subsidiary of Asahi Kasei) (Japan).

The patient handling equipment market is projected to reach USD 12.6 billion by 2024 from USD 8.9 billion in 2019, at a CAGR of 7.2% during the forecast period. The growth of this market is largely driven by factors such as the rising geriatric population, high risk of injuries to caregivers during the manual handling of patients, and the implementation of regulations ensuring the safety of healthcare personnel during manual lifting processes. However, the persistent difficulties in handling bariatric patients are expected to limit market growth to a certain extent.

Get Crucial Industry Insights | Download PDF Brochure:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=186358368

The patient transfer devices segment is expected to account for the largest share of the patient handling equipment market in 2019

Based on type, the market is segmented into mobility devices, medical beds, bathroom & toilet assist equipment, patient transfer devices, and stretchers & transport chairs. In 2019, the patient transfer devices segment is expected to account for the largest share of the market. The large share of this segment can primarily be attributed to factors such as the increasing installation of ceiling lifts in hospitals and the growing adoption of patient lifts for bariatric patient handling.

Based on end user, the hospitals segment dominates the patient handling equipment market in 2019

Based on end user, the patient handling equipment market is segmented into hospitals, home care settings, and other end users (elderly care facilities, emergency medical services, long-term acute care centers, trauma centers, and nursing homes). The hospitals segment is expected to account for the largest share of the market. The large share of this segment is attributed to the growing patient population, increasing geriatric population, rising number of disabled people, increasing number of injuries caused during the patient handling process, and the increasing preference for patient handling equipment over manual handling in hospitals.

Key Market Players:

The major companies in the patient handling equipment market include Arjo (Sweden), Invacare (US), and Hill-Rom Holdings (US).

Arjo (Sweden) has a broad range of patient handling equipment, which ensures safe and comfortable patient handling. With its strong geographical presence, brand image, and wide distribution network, the company is expected to hold a significant position in the market. Approximately 44% of Arjo’s total sales attributed to its patient lift, slings, stretchers, and medical bed portfolio. The company’s main customers are private and public institutions, providing acute and long-term care.

Get Expert Analysis and Insights of Global Market | Download Sample Report:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=186358368

Arjo has consistently focused on prioritizing product design and user-friendliness in the development of new and existing products in order to maintain its position in this market. In 2018, Arjo’s research and development costs amounted to USD 16.2 million, which corresponded to 1.7% of its sales. This has significantly helped the company in conducting customer-focused research and developing enhanced solutions to solve complex business challenges.

The global veterinary infectious disease diagnostics market is projected to reach USD 2.2 billion by 2024 from USD 1.4 billion in 2019, at a CAGR of 8.4%. The growth of this market is driven by the growing advancements in diagnostic devices, growth in the companion animal population, rising demand for pet insurance, growth in the number of veterinary practitioners in developed economies, and increasing disease control & disease prevention measures.

Some of the prominent players in the veterinary infectious disease diagnostics market include IDEXX Laboratories, Inc. (US), Zoetis, Inc. (US), QIAGEN N.V. (Indical GmbH) (Germany), Thermo Fisher Scientific, Inc. (US), Neogen Corporation (US), Virbac (France), bioMérieux SA (France), IDVet (France), Randox Laboratories, Ltd. (UK), and Heska Corporation (US).

Get Crucial Industry Insights | Download PDF Brochure Now:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=221816584

Analysis of the developments in the veterinary infectious disease diagnostics market between 2016 and 2019 shows that product launches, market expansions, agreements, partnerships, collaborations, and acquisitions were the most widely adopted growth strategies by players in the market to strengthen their positions.

Idexx Laboratories, Inc. (US) dominated the veterinary infectious disease diagnostics market in 2018. The company offers a broad range of products integral to the market, which are used widely in key regions such as North America, Europe, Asia Pacific, Africa, and the Middle East. Idexx mainly focuses on the development of innovative products to further strengthen its position in the veterinary infectious disease diagnostics market. Some key offerings of the company include SNAP Pro analyzers, SNAP test kits, ELISA kits, SediVue Urine Analyzer, among other products.

Zoetis, Inc. (US) led at the second position in the veterinary infectious disease diagnostics market in 2018. The company has a prominent presence in major markets, such as the US, Brazil, China, and Canada. To strengthen its current position and gain a larger share of the veterinary infectious disease diagnostics market, the company focuses on enhancing the breadth of its product offering. The company also focuses on partnerships and expansions. For example, the company set up a manufacturing facility in China and is also developing infrastructure in Ethiopia, Uganda, and Nigeria.

Get Complete Analysis of Global Market:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=221816584

What is the future growth analysis of global Physiotherapy Equipment Market?

The physiotherapy equipment market is projected to reach USD 21.1 billion by 2024 from USD 15.1 billion in 2018, at a CAGR of 5.8%.

What are key factors driving growth of global physiotherapy equipment market?

Growth in physiotherapy market is driven by rapidly growing geriatric population and the subsequent increase in the global prevalence of chronic diseases, and growing incidence of sports injuries, degenerative joint disorders, and cerebrovascular disease.

What the growth opportunities are in physiotherapy equipment market?

1. Emerging Markets
2. Technological Advances

Know more, Download PDF Brochure Now:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=65250228

Global Market Segmentation:

In the current market scenario, there is a growing demand for physiotherapy equipment. The physiotherapy market has been categorized based on products, application and region.

The electrotherapy equipment segment is projected to hold the largest share of the market, during the forecast period. The large share of the segment is primarily attributed to the by rapid adoption electrical stimulation-based techniques in rehabilitation. It includes techniques, such as Transcutaneous Electrical Nerve Stimulation, Functional Neuromuscular Stimulation, H-wave Stimulation, Neuromuscular Electrical Stimulation, Interferential Stimulation, Microcurrent Stimulation, Galvanic Stimulation, Sympathetic Therapy, Peripheral Subcutaneous Field Stimulation, Peroneal Nerve Stimulation, and Auricular Stimulation (P-stim).

On the basis of application, the physiotherapy market is segmented into cardiovascular and pulmonary applications, musculoskeletal applications, neurological applications, pediatric applications, gynecological applications, and other applications (includes sports and palliative care). In 2018, the musculoskeletal applications segment accounted for the largest share of the market, followed by the neurological applications segment. The large share of the musculoskeletal applications segment is attributed to the rising incidence of musculoskeletal disorders, growth in the geriatric population, and the increasing number of accidents.

Recent Developments in Global Physiotherapy Equipment Market:

1. In 2018, DJO entered into a strategic partnership with XPO Logistics, to manage portions of DJO’s North American distribution operations.

2. In 2017, Dynatronics partnered with Orthopedic Outfitters to distribute Dynatronics’ physiotherapy and rehabilitation products.

Geographic Growth Analysis:

The physiotherapy equipment market is predominantly divided into four major geographies, namely, North America, Europe, Asia Pacific, and the Rest of the World. Europe accounted for the largest share of physiotherapy market, followed by North America.

The major drivers for the growth of this market are the rising geriatric population, increasing inclination for active lifestyles, the penetration of physiotherapy services, and favorable healthcare reforms. However, an uncertain reimbursement scenario and the need for reforms in physiotherapy educational practices are hindering the growth of physiotherapy market.

Request Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=65250228

Key Players In Global Physiotherapy Equipment Market:

The major physiotherapy equipment vendors include DJO Global (US), Performance Health (US), BTL Industries (US), and EMS Physio (UK).

Also get Information about:

1. Who are the major market players in the physiotherapy equipment and accessories market?

2. What are the growth trends and the largest revenue-generating region for physiotherapy equipment?

3. How are physiotherapy equipment sold to customers?

4. What are the major types of physiotherapy equipment and accessories?

5. What are the driving, restraining, opportunistic, and challenging factors for physiotherapy market?

What is the future growth analysis of global 3D Cell Culture Market?

The 3D cell culture market is expected to reach USD 1,846 million in 2024 from USD 892 million in 2019 growing at a CAGR of 15.7%

What are key factors driving growth of global 3D Cell Culture Market?

The growth of this market is driven mainly by the increasing focus on developing alternatives to animal testing, growing focus on personalized medicine, increasing incidence of chronic diseases, and the availability of funding for research. On the other hand, the lack of infrastructure for 3D cell-based research and the high cost of cell biology research are expected to restrain the growth of this market during the forecast period.

What the growth opportunities are in 3D Cell Culture Market?

1. Untapped Emerging Markets
2. Emergence of Microfluidics-Based 3D Cell Culture
3. Regenerative Medicine, an Alternative to Organ Transplantation

Get More Crucial Insights:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=191072847

Global Market Segmentation:

In the current market scenario, there is a growing demand for 3D cell culture. The market has been categorized based on the product, end user, application, and region.

Based on application, the 3D cell culture market is segmented into cancer & stem cell research, drug discovery & toxicology testing, and tissue engineering & regenerative medicine. The cancer & stem cell research segment accounted for the largest share of the market in 2018 and is expected to register the highest CAGR during the forecast period. The increasing prevalence of cancer and significant funding for cancer research are major factors driving the growth of this application segment.

Based on product, the market is segmented into scaffold-based 3D cell cultures, scaffold-free 3D cell cultures, microfluidics-based 3D cell cultures, and magnetic & bioprinted 3D cell cultures. Scaffold-based 3D cell cultures accounted for the largest share of the market in 2018. The advantages of scaffolds in 3D cell culture, such as structural rigidity and the availability of attachment points, have greatly driven the preference for scaffold-based 3D cell cultures and ensured the large share of this segment.

Based on end user, the market is segmented into pharmaceutical & biotechnology companies, research institutes, the cosmetics industry, and other end users. Pharmaceutical & biotechnology companies accounted for the largest share of the market in 2018. The presence of a large number of pharmaceutical & biotechnology companies, an increase in R&D spending in these companies, and the growing preference for alternative testing models over animal techniques are the key market drivers in this end-user segment.

Geographic Growth Analysis 3D Cell Culture Market:

North America commanded the largest share of the market due to the increasing incidence of cancer and the presence of a well-established pharmaceutical & biotechnology industry. However, the market in Europe is expected to grow at the highest CAGR during the forecast period. The growth of the market in Europe is attributed to the growth of its pharmaceutical and biotechnology industry, recent commercialization of microfluidics-based products, the increasing presence of major market players, and a large number of research activities conducted in the region.

Get Expert Analysis and Insights of Global Market | Download Sample Report:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=191072847

Key Players In Global 3D Cell Culture Market:

Thermo Fisher Scientific (US), Corning Incorporated (US), Merck KGaA (Germany), Lonza AG (Switzerland), REPROCELL Incorporated (Japan), TissUse (Germany), InSphero (Switzerland), Synthecon (US), 3D Biotek (US), CN Bio (UK), Hamilton Company (US), MIMETAS (Netherlands), Emulate (US), Hµrel Corporation (US), QGel SA (Switzerland), SynVivo (US), Advanced BioMatrix (US), Greiner Bio-One International (Austria), and PromoCell (Germany).

The study involved four major activities to estimate the current market size for radiotherapy market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The demand side of this market is characterized by the increasing awareness about minimally invasive cancer treatment options and the global rise in the prevalence of cancer. The supply side is characterized by advancements in technology.

Objectives Of Study:

# To define, describe, and forecast the global radiotherapy market on the basis of type, product type, application, end user, and region

# To provide detailed information regarding the major factors (drivers, restraints, opportunities, challenges, and trends) influencing the growth of the global radiotherapy market

# To strategically analyze the micromarkets with respect to individual growth trends, future prospects, and contributions to the global radiotherapy market

# To analyze the opportunities in the global radiotherapy industry for key stakeholders and provide details of the competitive landscape for market leaders

# To forecast the size of the market segments with respect to four major regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World (Latin America and the Middle East & Africa)

Get Crucial Industry Insights:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=567

Market Size Estimation:

Both top-down and bottom-up approaches were used to estimate and validate the total size of the radiotherapy market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

# The key players in the industry and markets have been identified through extensive secondary research

# The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes

# All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

Factors Driving Market Growth:

Market growth is largely driven by factors such as technological advancements, the rising prevalence of cancer, the increasing number of conferences and symposia focusing on spreading awareness about the benefits of radiotherapy, and the growing use of particle therapy for cancer treatment. The emerging markets, growing government and private investments to meet the increasing demand for cancer treatment, and the improving reimbursement scenario are expected to present a wide range of growth opportunities for market players.

Global Market Scenario:

The radiotherapy market is projected to grow from an estimated USD 5.6 billion in 2018 to USD 6.8 billion by 2023, at a CAGR of 4.1%

Get Expert Analysis and Insights of Global Market | Download Sample Report:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=567

Recent Developments in Global Radiotherapy Market:

# In 2017, Mitsubishi Electric signed an agreement to transfer its particle therapy systems business to Hitachi and integrate into one entity.

# In 2017, Varian Medical Systems opened its new facility in Jundiai, Brazil. This expansion is aimed to increase access to advanced radiotherapy treatment in the country.

# In 2016, Varian Medical Systems launched an innovative treatment platform-Halcyon Treatment System. The product simplifies treatment delivery with high-quality plans delivered at significantly increased speeds.

The study involved four major activities to estimate the current market size for radiotherapy market. Exhaustive secondary research was done to collect information on the market and its different subsegments. The demand side of this market is characterized by the increasing awareness about minimally invasive cancer treatment options and the global rise in the prevalence of cancer. The supply side is characterized by advancements in technology.

Objectives Of Study:

# To define, describe, and forecast the global radiotherapy market on the basis of type, product type, application, end user, and region

# To provide detailed information regarding the major factors (drivers, restraints, opportunities, challenges, and trends) influencing the growth of the global radiotherapy market

# To strategically analyze the micromarkets with respect to individual growth trends, future prospects, and contributions to the global radiotherapy market

# To analyze the opportunities in the global radiotherapy industry for key stakeholders and provide details of the competitive landscape for market leaders

# To forecast the size of the market segments with respect to four major regional segments, namely, North America, Europe, Asia Pacific, and the Rest of the World (Latin America and the Middle East & Africa)

Get Crucial Industry Insights:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=567

Market Size Estimation:

Both top-down and bottom-up approaches were used to estimate and validate the total size of the radiotherapy market. These methods were also used extensively to estimate the size of various subsegments in the market. The research methodology used to estimate the market size includes the following:

# The key players in the industry and markets have been identified through extensive secondary research

# The industry’s supply chain and market size, in terms of value, have been determined through primary and secondary research processes

# All percentage shares, splits, and breakdowns have been determined using secondary sources and verified through primary sources

Factors Driving Market Growth:

Market growth is largely driven by factors such as technological advancements, the rising prevalence of cancer, the increasing number of conferences and symposia focusing on spreading awareness about the benefits of radiotherapy, and the growing use of particle therapy for cancer treatment. The emerging markets, growing government and private investments to meet the increasing demand for cancer treatment, and the improving reimbursement scenario are expected to present a wide range of growth opportunities for market players.

Global Market Scenario:

The radiotherapy market is projected to grow from an estimated USD 5.6 billion in 2018 to USD 6.8 billion by 2023, at a CAGR of 4.1%

Get Expert Analysis and Insights of Global Market | Download Sample Report:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=567

Recent Developments in Global Radiotherapy Market:

# In 2017, Mitsubishi Electric signed an agreement to transfer its particle therapy systems business to Hitachi and integrate into one entity.

# In 2017, Varian Medical Systems opened its new facility in Jundiai, Brazil. This expansion is aimed to increase access to advanced radiotherapy treatment in the country.

# In 2016, Varian Medical Systems launched an innovative treatment platform-Halcyon Treatment System. The product simplifies treatment delivery with high-quality plans delivered at significantly increased speeds.

The Asia-Pacific region is expected to offer huge growth opportunities in Downstream Processing Market. Countries like China, Japan, India, and South Korea, are expected to drive the demand for downstream processing products in the coming years. Also, growth in these markets will be fueled by significant investments by key market players, increasing government support, developing R&D infrastructure, and growing expertise and academic excellence.

North America is the world’s largest pharmaceutical market and a leader in biopharmaceutical research. North America (comprising the U.S. and Canada) accounted for the largest share of the global market in 2016. Rising quality requirements have emphasized the need for advanced bioproduction technology in this region.

The growth of Downstream Processing Market is propelled by the increasing demand for biopharmaceuticals and increasing R&D expenditure in the biopharmaceutical industry. Emerging markets such as Asia-Pacific provide new growth opportunities to players in the market.

Get Crucial Insights:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=73180930

Global Market Segmentation:

In this report, the global Downstream Processing Market is broadly segmented by technique, product, application, end user, and region

On the basis of product, the market is classified into chromatography columns and resins, filters, membrane adsorbers, single-use products, and other products.

Based on technique, the market is segmented into purification, solid-liquid separation, and clarification/concentration. In 2016, the purification segment accounted for the largest share of the market. This high growth is attributed to the need for highly pure biopharmaceutical products to meet the regulatory standards, as downstream purification plays a significant role in enhancing the purity and quality of products aiding the growth of the purification market.

Based on application, the downstream processing market is categorized into monoclonal antibody (mAbs) production, vaccine production, insulin production, immunoglobulin production, erythropoietin production, and other applications. In 2016, the vaccine production segment accounted for the largest share of the market. Technological advancement in the downstream purification technology to develop high-quality products such as Vaccines at lower costs is expected to drive the growth of this segment.

Based on end user, the market is segmented into biopharmaceutical manufacturers and contract manufacturing organizations (CMOs). In 2016, the biopharmaceutical manufacturers segment accounted for the largest share of the market. The increasing demand for biopharmaceuticals among the aging population is expected to accelerate the growth of the biopharmaceutical manufacturers’ end-user segment.

Get Expert Analysis and Insights of Global Market | Download Sample Report:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=73180930

Key Players in Downstream Processing Market:

The market is dominated by established players such as Thermo Fisher Scientific Inc. (U.S.), GE Healthcare (U.S.), Sartorius Stedim Biotech S.A. (France), Merck Millipore (Germany), and Danaher Corporation (U.S.).

Stakeholders:

# Vendors/service providers
# Research and consulting firms
# Biopharmaceutical manufacturers
# Contract manufacturing organizations (CMOs)
# Contract research organizations (CROs)

This research study involved the top down and bottom up approaches to estimate and validate the size of the Healthcare Consulting Services Market size. Various secondary sources such as the World Health Organization, National Society of Certified Healthcare Business Consultants, American Association of Healthcare Consultants, European Health Management Association, have been used to identify and collect information useful for this extensive commercial study of the healthcare consulting services industry.

Objectives of Study:

# To define, describe, and forecast the healthcare consulting services market (by value) on the basis of the type of service, end user, and region

# To identify micromarkets and the drivers, restraints, industry-specific challenges, opportunities, and trends affecting the growth of the market

# To strategically analyze market segments and subsegments with respect to individual growth trends, prospects, and contributions to the overall market

# Forecast revenue of the market with respect to four main regional segments, namely, North America, Europe, Asia Pacific, the Middle East & Africa, and Latin America

# To analyze market opportunities for stakeholders and provide details of the competitive landscape for key players

# To profile key players and comprehensively analyze their market shares and core competencies in terms of market developments and growth strategies

Get Crucial Insights:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=41882774

Target Audience for This Report:

# Companies partnering with healthcare consulting services
# Market research and consulting firms
# Healthcare providers
# Healthcare payers
# Government institutions

Healthcare Consulting Services:

# IT Consulting
# Digital Consulting
# Financial Consulting
# Operations Consulting
# Strategy Consulting
# HR and Talent Consulting

Major Factors Driving Growth In Healthcare Consulting Services Market:

Market growth is primarily driven by the growing geriatric population, the rising importance of value-based care; and technological advancements in healthcare.

Opportunities:

1. Consolidation in the U.S. Healthcare Market

Key Questions Answered in This Report:

1. What are the growth opportunities related to the adoption of healthcare consulting services across major regions in the future?

2. Emerging countries have immense opportunities for the growth of healthcare consulting services. Will this scenario continue in the next five years?

3. Where will all the advancements offered by various companies take the industry in the mid- to long-term?

4. What are the new trends and advancements in the market?

Please share your specific interest to serve you better.
Download Sample Pages: https://www.marketsandmarkets.com/requestsampleNew.asp?id=41882774

What Expert Says About the Global Market Growth?

The global healthcare consulting services market is expected to reach USD 15.88 billion by 2023 from USD 8.99 billion in 2017 and, at a CAGR of 10.2%.

Geographical Growth Analysis:

The global healthcare consulting services market was dominated by North America, followed by Europe in 2017. Factors such as increasing M&A activity, pricing pressure on pharmaceutical companies are driving the growth of the healthcare consulting services market in this region. Asia Pacific, however, is estimated to register the highest CAGR during the forecast period due to the increasing need for remote care and telemedicine in rural areas in the region.

Key Market Players:

# Delotte Touche Tohmatsu Limited
# McKinsey & Company
# Accenture Consulting
# Huron Consulting
# PWC
# Ernst & Young
# The Boston Consulting Group
# KPMG
# Cognizant

Factors driving growth in Healthcare Business Intelligence Market are the implementation of government initiatives to increase EHR adoption, growing adoption of data-driven decision-making, growing pressure to curb healthcare spending and improve patient outcomes, big data in healthcare, and the increasing number of patient registries.

The healthcare business intelligence platforms segment are expected to account for the largest share of the market. The large share of this market segment is mainly driven by the increasing requirement for customized BI solutions catering to individual requirements of organizations and allowing them the flexibility to build and integrate BI solutions into existing healthcare business applications for higher efficiency and reduced costs.

Get Crucial Insights:
https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=252368925

Q: What is the market size of Healthcare Business Intelligence Market?
Ans: The global market size of Healthcare Business Intelligence Market is projected to reach USD 8.9 billion by 2023, from an estimated USD 4.4 billion in 2018

Q: What is the forecast period considered in Healthcare Business Intelligence Industry Report?
Ans: Forecast period considered for Healthcare Business Intelligence Market is 2018–2023.

Q: What is the growth rate of Healthcare Business Intelligence Market?
Ans: The Healthcare Business Intelligence Market is growing at a CAGR of 15.3%

Q: What segments are covered in Healthcare Business Intelligence Forecast Report?
Ans: Segments covered in Healthcare Business Intelligence Market are Component, Application, End User and Region.

Q: What geographies are covered in Healthcare Business Intelligence Industry Analysis Report?
Ans: Major geographies covered in Healthcare Business Intelligence Market are North America, Europe, the Asia Pacific, and the Rest of the World.

Q: Who are the key market players in Healthcare Business Intelligence Market Research Report?
Ans: The major players in the global market include Microsoft (US), IBM (US), Oracle (US), SAP SE (Germany), SAS Institute Inc. (US), Tableau Software (US), MicroStrategy Incorporated (US), QlikTech International AB (US), Information Builders (US), Sisense Inc. (US), Yellowfin BI (Australia), and BOARD International (Switzerland).

Q: Which region accounted for largest share in Healthcare Business Intelligence Market?
Ans: The North America region accounted for the largest share of the market in 2018

Financial analysis segment are expected to account for the largest share of the market. Due to the rising focus of payers on the early detection of fraud and reducing preventable costs, the market for financial analysis is expected to register a significant growth during the forecast period.

The payers segment is expected to account for the largest share of the market. Factors such as rising healthcare costs; the growing need to increase memberships and curb fraudulent claims, optimize provider networks, and reduce operational costs; and increasing competition are compelling healthcare payers to adopt BI solutions.

Request Sample Pages:
https://www.marketsandmarkets.com/requestsampleNew.asp?id=252368925

The high growth of the North American market can be attributed to the increasing adoption of healthcare intelligence solutions and services by healthcare providers (especially in the US) to provide better quality care and lower healthcare costs is a major factor driving market growth.